These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34845456)

  • 1. A modified porous silicon microparticle promotes mucosal delivery of SARS-CoV-2 antigen and induction of potent and durable systemic and mucosal T helper 1 skewed protective immunity.
    Adam A; Shi Q; Wang B; Zou J; Mai J; Osman SR; Wu W; Xie X; Aguilar PV; Bao X; Shi PY; Shen H; Wang T
    bioRxiv; 2021 Nov; ():. PubMed ID: 34845456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine.
    Adam A; Shi Q; Wang B; Zou J; Mai J; Osman SR; Wu W; Xie X; Aguilar PV; Bao X; Shi PY; Shen H; Wang T
    Transl Res; 2022 Nov; 249():13-27. PubMed ID: 35688318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Systemic and Mucosal Humoral Immune Responses to an Adjuvanted Intranasal SARS-CoV-2 Protein Subunit Vaccine Candidate in Mice.
    Maltseva M; Galipeau Y; Renner TM; Deschatelets L; Durocher Y; Akache B; Langlois MA
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen.
    Lan J; Deng Y; Chen H; Lu G; Wang W; Guo X; Lu Z; Gao GF; Tan W
    PLoS One; 2014; 9(11):e112602. PubMed ID: 25405618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2.
    Solis-Andrade KI; Gonzalez-Ortega O; Govea-Alonso DO; Comas-Garcia M; Rosales-Mendoza S
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2.
    Jearanaiwitayakul T; Seesen M; Chawengkirttikul R; Limthongkul J; Apichirapokey S; Sapsutthipas S; Phumiamorn S; Sunintaboon P; Ubol S
    Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern.
    Goel RR; Painter MM; Apostolidis SA; Mathew D; Meng W; Rosenfeld AM; Lundgreen KA; Reynaldi A; Khoury DS; Pattekar A; Gouma S; Kuri-Cervantes L; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; Baxter AE; Oldridge DA; Giles JR; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Drapeau EM; Dougherty J; Long S; D'Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; ; Frank I; Betts MR; Vella LA; Grifoni A; Weiskopf D; Sette A; Hensley SE; Davenport MP; Bates P; Luning Prak ET; Greenplate AR; Wherry EJ
    bioRxiv; 2021 Aug; ():. PubMed ID: 34462751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung.
    Routhu NK; Cheedarla N; Bollimpelli VS; Gangadhara S; Edara VV; Lai L; Sahoo A; Shiferaw A; Styles TM; Floyd K; Fischinger S; Atyeo C; Shin SA; Gumber S; Kirejczyk S; Dinnon KH; Shi PY; Menachery VD; Tomai M; Fox CB; Alter G; Vanderford TH; Gralinski L; Suthar MS; Amara RR
    Nat Commun; 2021 Jun; 12(1):3587. PubMed ID: 34117252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2.
    Park KS; Bazzill JD; Son S; Nam J; Shin SW; Ochyl LJ; Stuckey JA; Meagher JL; Chang L; Song J; Montefiori DC; LaBranche CC; Smith JL; Xu J; Moon JJ
    J Control Release; 2021 Feb; 330():529-539. PubMed ID: 33358977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent RBD-specific neutralizing rabbit monoclonal antibodies recognize emerging SARS-CoV-2 variants elicited by DNA prime-protein boost vaccination.
    Chen Y; Zhu L; Huang W; Tong X; Wu H; Tao Y; Tong B; Huang H; Chen J; Zhao X; Lou Y; Wu C
    Emerg Microbes Infect; 2021 Dec; 10(1):1390-1403. PubMed ID: 34120577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques.
    Sui Y; Li J; Zhang R; Prabhu SK; Andersen H; Venzon D; Cook A; Brown R; Teow E; Velasco J; Greenhouse J; Putman-Taylor T; Campbell TA; Pessaint L; Moore IN; Lagenaur L; Talton J; Breed MW; Kramer J; Bock KW; Minai M; Nagata BM; Lewis MG; Wang LX; Berzofsky JA
    JCI Insight; 2021 Apr; 6(10):. PubMed ID: 33908897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Subunit Vaccine with a Combination of TLR1/2 and TLR3 Agonists Induces Robust and Protective Immunity.
    Jeong SK; Heo YK; Jeong JH; Ham SJ; Yum JS; Ahn BC; Song CS; Chun EY
    Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2.
    Cao H; Mai J; Zhou Z; Li Z; Duan R; Watt J; Chen Z; Bandara RA; Li M; Ahn SK; Poon B; Christie-Holmes N; Gray-Owen SD; Banerjee A; Mossman K; Kozak R; Mubareka S; Rini JM; Hu J; Liu J
    Cell Biosci; 2021 Dec; 11(1):202. PubMed ID: 34879865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge.
    Wong TY; Lee KS; Russ BP; Horspool AM; Kang J; Winters MT; Allison Wolf M; Rader NA; Miller OA; Shiflett M; Izac J; Varisco D; Sen-Kilic E; Cunningham C; Cooper M; Cyphert HA; Barbier M; Martinez I; Bevere JR; Ernst RK; Damron FH
    NPJ Vaccines; 2022 Mar; 7(1):36. PubMed ID: 35288576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicomponent intranasal adjuvant drives durable humoral, cellular, and mucosal immune responses to SARS-CoV-2 in young and aged mice.
    Jangra S; Landers JJ; Laghlali G; Rathnasinghe R; O'Konek JJ; Janczak KW; García-Sastre A; Baker JR; Schotsaert M; Wong PT
    Res Sq; 2023 Jan; ():. PubMed ID: 36711479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Cycle Influenza A Virus-Based SARS-CoV-2 Vaccine Elicits Potent Immune Responses in a Mouse Model.
    Koonpaew S; Kaewborisuth C; Srisutthisamphan K; Wanitchang A; Thaweerattanasinp T; Saenboonrueng J; Poonsuk S; Jengarn J; Viriyakitkosol R; Kramyu J; Jongkaewwattana A
    Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation.
    Jeong H; Choi YM; Seo H; Kim BJ
    Front Immunol; 2021; 12():637654. PubMed ID: 33732258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterologous Systemic Prime-Intranasal Boosting Using a Spore SARS-CoV-2 Vaccine Confers Mucosal Immunity and Cross-Reactive Antibodies in Mice as well as Protection in Hamsters.
    Katsande PM; Fernández-Bastit L; Ferreira WT; Vergara-Alert J; Hess M; Lloyd-Jones K; Hong HA; Segales J; Cutting SM
    Vaccines (Basel); 2022 Nov; 10(11):. PubMed ID: 36366408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.